Madrigal Pharma(MDGL.US)

Event Tracking

Feb19

Madrigal Pharma released FY2025 annual earnings on February 19 Pre-Market EST, actual revenue USD 958.4 M (forecast USD 949.73 M), actual EPS USD -12.8501 (forecast USD -10.7609)

14:30

Madrigal Pharma released FY2025 Q4 earnings on February 19 Pre-Market (EST), actual revenue USD 0 (forecast USD 312.74 M), actual EPS USD 0 (forecast USD -0.5384)

14:30

Skandinaviska Enskilda Banken AB Significantly Increases Holdings in Madrigal Pharmaceuticals

10:11

Feb12

Madrigal Pharma to release FY2025 Q4 earnings on February 19, Pre-Market EST; forecast revenue USD 312.72 M, EPS USD -0.4654

00:19

Feb11

Madrigal Enters into Global License Agreement with Suzhou Ribobi Life Science to Expand MASH Treatment Pipeline

10:00

Jan13

Madrigal Pharmaceuticals Showcases Pfizer Assets and Rezdiffra Success, Aims to Lead MASH Market

23:33